AstraZeneca Surges as Global Demand for Specialist Cancer Treatments Drives Record Profit Growth
AstraZeneca has delivered a robust financial performance in its latest quarterly report, underpinned by an aggressive expansion into oncology and rare disease
by 
Josh Weiner
Josh Weiner